Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.

Rogler A, Rogenhofer M, Borchardt A, Lunz JC, Knoell A, Hofstaedter F, Tannapfel A, Wieland W, Hartmann A, Stoehr R.

Pathobiology. 2011;78(4):193-200. doi: 10.1159/000326767. Epub 2011 Jul 19.

2.

Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.

Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S, Siddiqi M.

Cancer Genet Cytogenet. 2010 Dec;203(2):263-8. doi: 10.1016/j.cancergencyto.2010.08.010.

PMID:
21156242
3.

p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.

Pantelis A, Pantelis D, Ruemmele P, Hartmann A, Hofstaedter F, Buettner R, Bootz F, Stoehr R.

Oncol Rep. 2007 May;17(5):1243-8.

PMID:
17390072
5.

Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer.

Salehi Z, Hadavi M.

J Med Virol. 2012 Sep;84(9):1423-7. doi: 10.1002/jmv.23268.

PMID:
22825821
6.

p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population.

Sreeja L, Syamala V, Raveendran PB, Santhi S, Madhavan J, Ankathil R.

Cancer Invest. 2008 Feb;26(1):41-6. doi: 10.1080/07357900701638459.

PMID:
18181044
7.

TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.

Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM.

Cancer Genet Cytogenet. 2008 Jan 1;180(1):14-9.

PMID:
18068527
8.

Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil.

Pinto GR, Yoshioka FK, Silva RL, Clara CA, Santos MJ, Almeida JR, Burbano RR, Rey JA, Casartelli C.

Genet Mol Res. 2008 Feb 26;7(1):207-16.

PMID:
18393224
9.

Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.

Parhar P, Ezer R, Shao Y, Allen JC, Miller DC, Newcomb EW.

Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):98-103. Epub 2005 Mar 21.

PMID:
15950766
10.

Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.

Lind H, Ekstrøm PO, Ryberg D, Skaug V, Andreassen T, Stangeland L, Haugen A, Zienolddiny S.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2077-81.

11.

p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.

Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, Yu CC, Wu TT, Lee YH, Huang JK, Huang CH.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2217-24.

12.

P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population.

Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wei Q.

Oncol Rep. 2004 May;11(5):1115-20.

PMID:
15069555
13.

p53 codon 72 polymorphism and its association with bladder cancer.

Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA.

Cancer Lett. 2002 May 28;179(2):175-83.

PMID:
11888672
14.

TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.

Sameer AS, Shah ZA, Syeed N, Banday MZ, Bashir SM, Bhat BA, Siddiqi MA.

Genet Mol Res. 2010 Apr 13;9(2):651-60. doi: 10.4238/vol9-2gmr751.

15.

Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk.

Li MS, Liu JL, Wu Y, Wang P, Teng H.

Genet Mol Res. 2011 Nov 29;10(4):2924-33. doi: 10.4238/2011.November.29.3.

16.

Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.

Yamashita T, Yaginuma Y, Saitoh Y, Kawai K, Kurakane T, Hayashi H, Ishikawa M.

Carcinogenesis. 1999 Sep;20(9):1733-6.

PMID:
10469618
17.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
18.
19.

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

Zheng SL, Augustsson-Bälter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Grönberg H.

Cancer Res. 2004 Apr 15;64(8):2918-22.

20.

Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women.

Bhattacharya P, Duttagupta C, Sengupta S.

Cancer Lett. 2002 Dec 15;188(1-2):207-11.

PMID:
12406566

Supplemental Content

Support Center